🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Bristol-Myers Squibb Company

BMY Healthcare
$62.32 $-0.59 (-0.94%)
Market Cap: $127.39 B
Gurus Holding
16
Popularity Rank
#95
% of Shares Held
2.19%
Net Activity (Q2 2026)
-$223.31 M

Guru Ownership Trend

Guru Analysis for Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 16 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.79 B.

Top institutional holders include Cliff Asness and Richard Pzena.

Institutional sentiment is currently Bearish. This is evidenced by a $223.31 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Jefferies Group reduced exposure by 17.7%.

Key Holders

Top 5 by Value

$1.58 B
$888.88 M
$51.45 M
$40.13 M
$26.13 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$24.07 M
Total Buy Value
New Buys 0
Additions 5
-$247.38 M
Total Sell Value
Reductions 9
Sold Out 3

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
12
Net Buyers
5

FAQs for Bristol-Myers Squibb Company (BMY)

Major holders include Cliff Asness ($1.58 B), Richard Pzena ($888.88 M), Joel Greenblatt ($51.45 M). According to the latest reported data, 16 tracked investment managers collectively hold approximately 44.77 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $223.31 M, with 5 managers increasing positions and 12 managers reducing holdings.

During the most recent reporting period, 9 managers trimmed their positions, while 3 fully exited BMY. The total reported sell value was $247.38 M.

Yes, 0 managers opened new positions in BMY, and 5 increased their existing holdings. The total reported buy value was $24.07 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.55% Reduce -7.7% 27,357,486 $1.58 B Q2 2026
2.61% Reduce -16.2% 14,244,839 $888.88 M Q3 2026
0.12% Add 3.6% 892,969 $51.45 M Q2 2026
0.40% Reduce -3.5% 696,430 $40.13 M Q2 2026
0.19% Reduce -17.7% 418,780 $26.13 M Q3 2026
0.05% Reduce -4.8% 411,483 $23.71 M Q2 2026
0.00% Add 22.9% 213,131 $13.3 M Q3 2026
0.14% Add 0.9% 184,742 $10.82 M Q2 2026
0.05% Reduce -0.7% 82,073 $5.12 M Q3 2026
0.95% 69,500 $4 M Q2 2026
0.22% Add 15.0% 43,200 $2.7 M Q3 2026
0.03% Reduce -3.9% 42,814 $2.67 M Q3 2026
1.89% Reduce -14.8% 45,235 $2.61 M Q2 2026
0.01% Add 2.0% 24,684 $1.42 M Q2 2026
0.17% Reduce -0.8% 21,671 $1.25 M Q2 2026
0.00% New Buy 18,200 $1.14 M Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form